Biochips Market in North America 2014-2018

Biochips Market in North America 2014-2018

Category : Diagnostic and Biotech
Published On : January  2014
Pages : 63


------------ Or -------------

TechNavio's analysts forecast the Biochips market in North America to grow at a CAGR of 10.24 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need for high-speed diagnosis. The Biochips market in North America has also been witnessing the increasing outsourcing activities by drug manufacturers. However, the high cost incurred in the implementation of biochips could pose a challenge to the growth of this market. 
TechNavio's report, the Biochips Market in North America 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on North America; it also covers the Biochips market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc., Becton, Dickinson and Co., bioMérieux S.A., BioRad Laboratories, Cepheid Inc., Danaher Corp., GE Healthcare Ltd., Microarrays Inc., Qiagen N.V, Promega Corp., Illumina Inc., Life Technologies Corp., Roche Holding AG, Perkin Elmer Inc., and Siemens Healthcare Diagnostics.
Key questions answered in this report: 
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Category

07.1 Biochips Market in North America by Category

08. Market Segmentation by Product

08.1 Biochips Market in North America by Product

09. Market Segmentation by Application

09.1 Biochips Market in North America by Application

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Affymetrix Inc.

18.1.1 Business Overview

18.1.2 Business Segmentation

18.1.3 Key Information

18.1.4 SWOT Analysis

18.2 Agilent Technologies

18.2.1 Business Overview

18.2.2 Key Information

18.2.3 SWOT Analysis

18.3 Life Technologies Corp.

18.3.1 Business overview

18.3.2 Business Segmentation

18.3.3 Key Information

18.3.4 SWOT Analysis

18.4 Illumina Inc.

18.4.1 Business Overview

18.4.2 Business Segmentation

18.4.3 Key Information

18.4.4 SWOT Analysis

18.5 Roche Holding AG

18.5.1 Business Overview

18.5.2 Business Segmentation

18.5.3 Key Information

18.5.4 SWOT Analysis

19. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Classification of the Biochips market in North America

Exhibit 3: Biochips Market in North America 2013-2018 (US$ billion)

Exhibit 4: Biochips Market in North America  Segmentation by Category

Exhibit 5: Biochips Market in North America  Segmentation by Category 2013

Exhibit 6: Biochips Market in North America  Segmentation by Product

Exhibit 7: Biochips Market in North America  Segmentation by Product 2013

Exhibit 8: Biochips Market in North America  Segmentation by Application

Exhibit 9: Business Segmentation of Affymetrix Inc.

Exhibit 10: Business Segmentation of Agilent Technologies Inc.

Exhibit 11: Business Segmentation of Life Technologies Corp.

Exhibit 12: Business Segmentation of Illumina Inc.

Exhibit 13: Business Segmentation of Roche Holding AG


Enquiry Before Buy